certolizumab pegol Injection

Brand(s)
Cimzia
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Ucb, Inc. (2015-10-23)
Oldest Current Product
2008-04-20
License(s)
BLA
RxNORM
INJECTION\CERTOLIZUMAB PEGOL

product(s) by strength(s)

certolizumab pegol 200 mg injection

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)dose formapplicationspl
1504740700CimziaBLAUcb, Inc.2008-04-20CERTOLIZUMAB PEGOLKIT125160b4c2c9dc-a0bb-4d64-a667-a67ebe88392d

application(s)

#idtitleapprovedtradenamesfda division
1125160certolizumab pegol Application2008-04-22CimziaCDER

spl(s)

#idtitlecategorytypelabelerlast updateversionproduct(s)in other drug docs
1b4c2c9dc-a0bb-4d64-a667-a67ebe88392d (view SPL)These highlights do not include all the information needed to use CIMZIA safely and effectively. See full prescribing information for CIMZIA. CIMZIA (certolizumab pegol) for injection, for subcutaneous use CIMZIA (certolizumab pegol) injection, for subcutaneous use Initial U.S. Approval: 2008prescriptionHuman PrescriptionUcb, Inc.2015-10-2318504740700, 504740710certolizumab pegol Prefilled Syringe

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII